Inventor
ZENYU SHIOKAWA
Inventor
JP
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds22%
C07HSugars11%
PatentTitleYear
12,528,816Substituted imidazo [1,2-b] pyridazines and [1, 2, 4] triazolo [ 4,3-b] pyridazines as camkii inhibitors202612,247,0153-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2202512,171,777Methods of making a cyclic dinucleotide202411,795,172Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as CaMKII inhibitors202311,666,594Antibody-drug conjugates comprising a cyclic dinucleotide202311,197,858Substituted amines for treating cardiac diseases2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021Patents assigned to CARDURION PHARMACEUTICALS LLC (1)· patent assignee history
2021–2026Based in JP· patent location history
2023–2026Patents assigned to CARDURION PHARMACEUTICALS INC (2)· patent assignee history
2023–2024Patents assigned to TAKEDA PHARMACEUTICALS CO (2)· patent assignee history
2025Patents assigned to SOLENT THERAPEUTICS LLC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CARDURION PHARMACEUTICALS INC | 2 | 2023–2026 |
| TAKEDA PHARMACEUTICALS CO | 2 | 2023–2024 |
| CARDURION PHARMACEUTICALS LLC | 1 | 2021 |
| SOLENT THERAPEUTICS LLC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 6 | 2021–2026 |